TW201738215A - 1,5-苯并二氮呯化合物之結晶 - Google Patents

1,5-苯并二氮呯化合物之結晶 Download PDF

Info

Publication number
TW201738215A
TW201738215A TW106111670A TW106111670A TW201738215A TW 201738215 A TW201738215 A TW 201738215A TW 106111670 A TW106111670 A TW 106111670A TW 106111670 A TW106111670 A TW 106111670A TW 201738215 A TW201738215 A TW 201738215A
Authority
TW
Taiwan
Prior art keywords
crystal
compound
powder
type
ray diffraction
Prior art date
Application number
TW106111670A
Other languages
English (en)
Chinese (zh)
Inventor
Ryu Nakao
Original Assignee
Zeria Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeria Pharmaceutical Co Ltd filed Critical Zeria Pharmaceutical Co Ltd
Publication of TW201738215A publication Critical patent/TW201738215A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW106111670A 2016-04-08 2017-04-07 1,5-苯并二氮呯化合物之結晶 TW201738215A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016078254A JP2019131467A (ja) 2016-04-08 2016-04-08 １，５−ベンゾジアゼピン化合物の結晶

Publications (1)

Publication Number Publication Date
TW201738215A true TW201738215A (zh) 2017-11-01

Family

ID=60001251

Family Applications (1)

Application Number Title Priority Date Filing Date
TW106111670A TW201738215A (zh) 2016-04-08 2017-04-07 1,5-苯并二氮呯化合物之結晶

Country Status (3)

Country Link
JP (1) JP2019131467A (ja)
TW (1) TW201738215A (ja)
WO (1) WO2017175854A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110840898B (zh) * 2019-11-19 2022-05-13 湖南洞庭药业股份有限公司 光稳定化药物组合物及其制备方法和制药用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU721081B2 (en) * 1996-12-10 2000-06-22 Zeria Pharmaceutical Co., Ltd. 1,5-benzodiazepine derivatives
AU776283B2 (en) * 1999-12-02 2004-09-02 Zeria Pharmaceutical Co., Ltd. Calcium salts of 1,5-benzodiazepine derivatives, process for producing the salts and drugs containing the same

Also Published As

Publication number Publication date
WO2017175854A1 (ja) 2017-10-12
JP2019131467A (ja) 2019-08-08

Similar Documents

Publication Publication Date Title
JP5916752B2 (ja) ５−クロロ−ｎ２−（２−イソプロポキシ−５−メチル−４−ピペリジン−４−イル−フェニル）−ｎ４［２−（プロパン−２−スルホニル）−フェニル］−ピリミジン−２，４−ジアミンの結晶形
US10729678B2 (en) Preparation of and formulation comprising a MEK inhibitor
KR20080064908A (ko) 카르베딜올
WO2018184185A1 (zh) 奥扎莫德加成盐晶型、制备方法及药物组合物和用途
US8686153B2 (en) Lenalidomide salts
US10626089B2 (en) Quinoline derivative in crystal form
JP2011037844A (ja) ２−［［［２−［（ヒドロキシアセチル）アミノ］−４−ピリジニル］メチル］チオ］−ｎ−［４−（トリフルオロメトキシ）フェニル］−３−ピリジンカルボキサミドのベンゼンスルホン酸塩、その結晶、その結晶多形およびそれらの製造方法
CN111278808B (zh) 2-(5-(4-(2-吗啉代乙氧基)苯基)吡啶-2-基)-n-苄基乙酰胺的固体形式
TWI801421B (zh) 結晶
BRPI1009006B1 (pt) Forma Polimórfica de 6-(1H-imidazol-1-il)-2-fenil-quinazolina, seu processo de preparação, formulação e composição farmacêutica
TW201738215A (zh) 1,5-苯并二氮呯化合物之結晶
KR20180120273A (ko) Jak 관련 질병 예방 또는 치료용 약물의 염산 결정성 형태 및 이의 제조 방법
AU2020240301A1 (en) Crystalline and amorphous forms of N-(5-((4-ethylpiperazin-1-yl)methyl)pyridine-2-yl)-5-fluoro-4-(3-isopropyl-2-methyl-2H-indazol-5-yl)pyrimidin-2-amine and its salts, and preparation methods and therapeutic uses thereof
JP6357100B2 (ja) ６−（ピペリジン−４−イルオキシ）−２ｈ−イソキノリン−１−オン塩酸塩の結晶性溶媒和物
JP2014518236A (ja) ６−（ピペリジン−４−イルオキシ）−２ｈ−イソキノリン−１−オン塩酸塩の多形体
WO1999002522A1 (fr) (r)-n-(1-ethyl-1h-hexahydroazepine-3-yl)-6-methoxy-1h-benzotriazole-5-carbooxamide monofumarate monohydrate et son procede de production